Cargando…

Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream

Elastosis Perforans Serpiginosa (EPS) is a rare skin disease characterised by hyperkeratotic papules, transepidermal elimination of abnormal elastic fibres, and focal dermal elastosis. The aetiology is unknown, but an association with underlying systemic disorders, including Down syndrome has been d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gregersen, Pernille Axél, Stausbøl-Grøn, Birgitte, Ramsing, Mette, Sommerlund, Mette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211468/ https://www.ncbi.nlm.nih.gov/pubmed/25386246 http://dx.doi.org/10.4081/dr.2010.e15

Ejemplares similares

Elastosis perforans serpiginosa
por: de Rezende, Ludimila Noleto, et al.
Publicado: (2014)

Elastosis Perforans Serpiginosa
por: Lee, Si-Hyung, et al.
Publicado: (2014)

D-penicillamine-induced Elastosis Perforans Serpiginosa
por: Yao, Xue-Yan, et al.
Publicado: (2017)

Pulse Dye Laser Therapy Successful for Elastosis Perforans Serpiginosa
por: Rinaldi, Giulia, et al.
Publicado: (2019)

Penicillamine-induced elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum
por: Heusinkveld, Lauren E., et al.
Publicado: (2021)

Elastosis perforans serpiginosa: a review of the literature and our own experience
por: Polańska, Adriana, et al.
Publicado: (2016)

D-PENICILLAMINE INDUCED ELASTOSIS PERFORANS SERPIGINOSA MIMICKING ACNE KELOIDALIS NUCHAE
por: Pavithra, S, et al.
Publicado: (2011)

Elastosis perforans serpiginosa in a case of pseudoxanthoma elasticum: A rare association
por: Venkatachalam, Konakanchi, et al.
Publicado: (2016)

Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease
por: Samal, Swagatika, et al.
Publicado: (2020)

A Systematic Review of Case Reports of a Rare Dermatological Condition: Elastosis Perforans Serpiginosa
por: Besekar, Smruti M, et al.
Publicado: (2023)

D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin
por: Chisti, Muzamil Amin, et al.
Publicado: (2019)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
por: Mehta, Vandana, et al.
Publicado: (2008)

Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream
por: Riad, Hassan, et al.
Publicado: (2013)

Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
por: Yokoyama, Maiko, et al.
Publicado: (2019)

Successful Topical Treatment of Pigmented Purpuric Lichenoid Dermatitis of Gougerot-Blum in a Young Patient: A Case Report and Summary of the Most Common Pigmented Purpuric Dermatoses
por: Risikesan, Jeyanthini, et al.
Publicado: (2017)

GENITAL VITILIGO FOLLOWING USE OF IMIQUIMOD 5% CREAM
por: Zhang, Ruzhi, et al.
Publicado: (2011)

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009)

Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
por: Singal, Archana, et al.
Publicado: (2016)

Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2023)

Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
por: Jeon, Hye Chan, et al.
Publicado: (2011)

Coroiditis Serpiginosa-Like: revisión de Literatura
por: Arrieta-Bechara, César, et al.
Publicado: (2022)

Idiopathic hypereosinophilic syndrome: A rare diagnosis in children
por: Pallesen, Kristine Appel Uldall, et al.
Publicado: (2020)

Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
por: Benomar, Sophia, et al.
Publicado: (2009)

Efficacy of 5% Imiquimod Cream on Vulvar Intraepithelial Neoplasia in Korea: Pilot Study
por: Kim, Jeong-Min, et al.
Publicado: (2015)

Early Treatment with Imiquimod 5% Cream of Periungual Warts in Vietnam: The Poorer, the Better
por: Minh, Phuong Pham Thi, et al.
Publicado: (2019)

Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
por: Alatabani, Maram, et al.
Publicado: (2021)

Nodular Elastosis of the Pancreas
por: Wedel, Whitney, et al.
Publicado: (2015)

Malum Perforans in Diabetes
Publicado: (1913)

Reflectance Confocal Microscopy Follow-up of Multifocal Superficial Basal Cell Carcinomas Treated With Imiquimod 5% Cream
por: Zou, Yunmin, et al.
Publicado: (2022)

Optical Coherence Tomography as a Valuable Tool for the Evaluation of Cutaneous Kaposi Sarcoma Treated with Imiquimod 5% Cream
por: Cantisani, Carmen, et al.
Publicado: (2023)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
por: Torres, Abel, et al.
Publicado: (2007)

Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
por: Kopera, Daisy, et al.
Publicado: (2014)

Childhood Linear Focal Elastosis
por: Garg, Megha, et al.
Publicado: (2021)

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
por: Jamshaid, Humzah, et al.
Publicado: (2022)

Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
por: Hoyme, U B, et al.
Publicado: (2002)

Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013)

Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018)

Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
por: Karabulut, Gamze Ozturk, et al.
Publicado: (2017)

Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana
por: Fuentes-Nava, Gabriela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_plne5gos8osa0gu4iq10kfi4rf